ReproCELLorp (TSE:4978) Research & Development: 円627 Mil (TTM As of Dec. 2025)


TSE:4978 ReproCELL Incorp TSE:4978
58 GF Score
Price 円127.00
GF Value 円151.20
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is ReproCELLorp Research & Development?

ReproCELLorp TSE:4978 -3.79% 58 Research & Development is 円627 Mil as of Dec. 2025. GuruFocus rates TSE:4978 with a GF Score™ of 58/100 and a GF Value™ of 円151.20 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. ReproCELLorp's Research & Development for the three months ended in Dec. 2025 was 円157 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was 円627 Mil.

ReproCELLorp  (TSE:4978) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

ReproCELLorp Research & Development Related Terms

ReproCELLorp Research & Development Historical Data

* Premium members only.

The historical data trend for ReproCELLorp's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ReproCELLorp Research & Development Chart

ReproCELLorp Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 535.29 501.51 384.95 536.79 627.17

ReproCELLorp Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 170.92 162.40 146.10 157.32 161.34
TSE:4978
58GF Score
ReproCELL Incorp TSE:4978
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ReproCELLorp Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円627 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円627 Mil mean?
ReproCELLorp (TSE:4978) has a Research & Development of 円627 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on ReproCELLorp and its competitors.
Is ReproCELLorp's Research & Development too high?
ReproCELLorp's current Research & Development is 円627 Mil. Overall, ReproCELLorp has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ReproCELLorp's Research & Development compare to VRTX and REGN?
ReproCELLorp's Research & Development of 円627 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on ReproCELLorp and its competitors. ReproCELLorp's current Research & Development is 円627 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ReproCELLorp stock overvalued right now?
Based on GuruFocus' analysis, ReproCELLorp (TSE:4978) is currently considered Modestly Undervalued. The stock's GF Value™ is 円151.20, compared to a current price of 円127.00 — trading 16% below its estimated fair value. The current Research & Development is 円627 Mil. ReproCELLorp's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For ReproCELLorp (TSE:4978), the current Research & Development is 円627 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ReproCELLorp (TSE:4978) Overvalued in 2026?

Based on GuruFocus' analysis, ReproCELLorp stock appears to be undervalued. The current stock price of 円127.00 is trading 16% below its estimated GF Value™ of 円151.20. GuruFocus considers ReproCELLorp to be Modestly Undervalued.

Key valuation signals for TSE:4978:

  • Research & Development: 円627 Mil
  • GF Value™: 円151.20 vs. price of 円127.00 (16% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the TSE:4978 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ReproCELLorp Business Description

Address KDX Shin-Yokohama 381 Bldg. 9F, 3-8-11, Shin-Yokohama, Kohoku-ku, Kanagawa, Yokohama, JPN, 222-0033
ReproCELL Incorp is one of the leading stem cell research company in Japan. The company provides stem cell services, predictive drug discovery services, tissue services, and molecular services.
58GF Score

Get the complete analysis for TSE:4978

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円127.00
Price
円151.20
GF Value